 Betsy Risendal
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 18 | 2023 | 2435 | 2.220 |
Why?
| | Cancer Survivors | 5 | 2023 | 261 | 1.920 |
Why?
| | Patient Navigation | 4 | 2022 | 77 | 1.870 |
Why?
| | Survivors | 12 | 2015 | 458 | 1.620 |
Why?
| | Breast Neoplasms | 23 | 2022 | 2112 | 1.390 |
Why?
| | Colorectal Neoplasms | 7 | 2022 | 731 | 1.290 |
Why?
| | Community-Based Participatory Research | 1 | 2023 | 150 | 0.820 |
Why?
| | Delivery of Health Care | 8 | 2023 | 904 | 0.740 |
Why?
| | Health Plan Implementation | 3 | 2018 | 138 | 0.710 |
Why?
| | Early Detection of Cancer | 7 | 2023 | 349 | 0.660 |
Why?
| | Patient Care Planning | 4 | 2015 | 152 | 0.570 |
Why?
| | Patient Advocacy | 1 | 2017 | 73 | 0.540 |
Why?
| | Quality of Life | 4 | 2023 | 2712 | 0.490 |
Why?
| | Specialization | 1 | 2015 | 145 | 0.450 |
Why?
| | Research Design | 3 | 2023 | 1048 | 0.410 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 233 | 0.390 |
Why?
| | Registries | 2 | 2020 | 2008 | 0.390 |
Why?
| | Self Care | 1 | 2014 | 374 | 0.380 |
Why?
| | Health Equity | 2 | 2023 | 77 | 0.370 |
Why?
| | Mass Screening | 6 | 2022 | 1130 | 0.360 |
Why?
| | Humans | 54 | 2023 | 129706 | 0.360 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2014 | 1291 | 0.330 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 612 | 0.330 |
Why?
| | Cross-Sectional Studies | 10 | 2020 | 5050 | 0.330 |
Why?
| | Chronic Disease | 2 | 2015 | 1721 | 0.320 |
Why?
| | Patient-Centered Care | 1 | 2014 | 505 | 0.320 |
Why?
| | Indians, North American | 3 | 1999 | 615 | 0.320 |
Why?
| | Weight Gain | 1 | 2013 | 505 | 0.320 |
Why?
| | Middle Aged | 29 | 2022 | 31103 | 0.310 |
Why?
| | Aged | 21 | 2022 | 22113 | 0.300 |
Why?
| | Program Evaluation | 4 | 2022 | 880 | 0.290 |
Why?
| | Surveys and Questionnaires | 9 | 2022 | 5396 | 0.280 |
Why?
| | Logistic Models | 10 | 2019 | 1980 | 0.280 |
Why?
| | Family Health | 1 | 2008 | 199 | 0.280 |
Why?
| | Continuity of Patient Care | 3 | 2015 | 279 | 0.280 |
Why?
| | Safety-net Providers | 2 | 2018 | 109 | 0.270 |
Why?
| | Quality of Health Care | 1 | 2011 | 616 | 0.270 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1287 | 0.260 |
Why?
| | Female | 35 | 2022 | 68562 | 0.260 |
Why?
| | Case-Control Studies | 7 | 2020 | 3363 | 0.250 |
Why?
| | Capacity Building | 2 | 2023 | 58 | 0.250 |
Why?
| | Mammography | 3 | 2010 | 136 | 0.250 |
Why?
| | Primary Health Care | 4 | 2022 | 1668 | 0.240 |
Why?
| | Intergenerational Relations | | | 21 | NaN |
Why?
| | Survivorship | 2 | 2022 | 46 | 0.230 |
Why?
| | Odds Ratio | 5 | 2013 | 1025 | 0.230 |
Why?
| | Arizona | 4 | 2013 | 78 | 0.230 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 233 | 0.230 |
Why?
| | Adult | 25 | 2019 | 35596 | 0.220 |
Why?
| | Exercise | 1 | 2014 | 1931 | 0.210 |
Why?
| | Child Behavior | | | 236 | NaN |
Why?
| | Healthcare Disparities | 3 | 2017 | 571 | 0.190 |
Why?
| | Risk Factors | 13 | 2023 | 9832 | 0.180 |
Why?
| | United States | 14 | 2023 | 14078 | 0.180 |
Why?
| | Papanicolaou Test | 1 | 1999 | 43 | 0.160 |
Why?
| | Vaginal Smears | 1 | 1999 | 56 | 0.160 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2353 | 0.160 |
Why?
| | Health Priorities | 1 | 1999 | 35 | 0.160 |
Why?
| | Unemployment | 1 | 2019 | 42 | 0.160 |
Why?
| | Research | 3 | 2018 | 416 | 0.160 |
Why?
| | Patient Education as Topic | 2 | 2014 | 745 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2019 | 217 | 0.140 |
Why?
| | Age Factors | 7 | 2019 | 3145 | 0.140 |
Why?
| | Follow-Up Studies | 3 | 2015 | 4939 | 0.140 |
Why?
| | Preventive Medicine | 1 | 2017 | 40 | 0.130 |
Why?
| | Public Health | 1 | 2021 | 498 | 0.130 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 215 | 0.130 |
Why?
| | Comorbidity | 1 | 2020 | 1545 | 0.120 |
Why?
| | Health Planning | 1 | 2015 | 49 | 0.120 |
Why?
| | Health Status | 1 | 2020 | 751 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2022 | 568 | 0.120 |
Why?
| | Community Health Centers | 1 | 2014 | 61 | 0.120 |
Why?
| | Transition to Adult Care | 1 | 2015 | 74 | 0.110 |
Why?
| | Anniversaries and Special Events | 1 | 2014 | 16 | 0.110 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 105 | 0.110 |
Why?
| | Disease Management | 2 | 2015 | 596 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 776 | 0.110 |
Why?
| | Diffusion of Innovation | 1 | 2014 | 96 | 0.110 |
Why?
| | Health Behavior | 1 | 1999 | 755 | 0.110 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 228 | 0.110 |
Why?
| | Body Weight | 2 | 2013 | 935 | 0.110 |
Why?
| | Health Promotion | 2 | 2023 | 734 | 0.100 |
Why?
| | Colorado | 3 | 2015 | 4471 | 0.100 |
Why?
| | New Mexico | 1 | 2013 | 61 | 0.100 |
Why?
| | Age of Onset | 2 | 2019 | 494 | 0.100 |
Why?
| | Medical Oncology | 1 | 2015 | 274 | 0.100 |
Why?
| | Genetic Testing | 1 | 2015 | 425 | 0.100 |
Why?
| | Receptors, Estrogen | 3 | 2013 | 423 | 0.100 |
Why?
| | Vitamin B Complex | 1 | 2013 | 41 | 0.100 |
Why?
| | Incidence | 4 | 2019 | 2658 | 0.100 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 45 | 0.100 |
Why?
| | Male | 7 | 2020 | 63544 | 0.100 |
Why?
| | Methionine | 1 | 2013 | 159 | 0.100 |
Why?
| | Health Personnel | 1 | 2018 | 645 | 0.100 |
Why?
| | Socioeconomic Factors | 4 | 2013 | 1212 | 0.090 |
Why?
| | Folic Acid | 1 | 2013 | 182 | 0.090 |
Why?
| | Prognosis | 3 | 2022 | 3801 | 0.090 |
Why?
| | Health Services Accessibility | 2 | 2014 | 908 | 0.090 |
Why?
| | Obesity | 3 | 2013 | 2851 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2015 | 531 | 0.090 |
Why?
| | Patient Participation | 1 | 2014 | 403 | 0.090 |
Why?
| | Feasibility Studies | 1 | 2014 | 876 | 0.090 |
Why?
| | Patient Satisfaction | 1 | 2015 | 642 | 0.090 |
Why?
| | Survival Rate | 2 | 2011 | 1894 | 0.080 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 39 | 0.080 |
Why?
| | Southwestern United States | 4 | 2011 | 93 | 0.080 |
Why?
| | Interviews as Topic | 2 | 2013 | 698 | 0.080 |
Why?
| | Hydroxyestrones | 1 | 2009 | 2 | 0.080 |
Why?
| | Patient Care Team | 1 | 2014 | 607 | 0.080 |
Why?
| | Cohort Studies | 2 | 2022 | 5410 | 0.070 |
Why?
| | Confidence Intervals | 1 | 2008 | 319 | 0.070 |
Why?
| | Urinary Incontinence | 1 | 2008 | 62 | 0.070 |
Why?
| | Prospective Studies | 1 | 2013 | 7131 | 0.070 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 308 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1529 | 0.070 |
Why?
| | Parity | 2 | 2022 | 121 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 3 | 2010 | 2272 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 1999 | 1507 | 0.060 |
Why?
| | Patient Compliance | 1 | 2009 | 566 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2018 | 3054 | 0.060 |
Why?
| | Psychometrics | 2 | 2018 | 681 | 0.060 |
Why?
| | Smoking | 2 | 2023 | 1507 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1171 | 0.050 |
Why?
| | Phenotype | 1 | 2011 | 3063 | 0.050 |
Why?
| | School Teachers | 1 | 2022 | 20 | 0.050 |
Why?
| | Parenting | | | 291 | NaN |
Why?
| | Young Adult | 4 | 2019 | 12363 | 0.040 |
Why?
| | Child Development | | | 452 | NaN |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2424 | 0.040 |
Why?
| | Alcohol Drinking | 2 | 2011 | 745 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 997 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 332 | 0.040 |
Why?
| | Financing, Personal | 1 | 2019 | 25 | 0.040 |
Why?
| | Culture | 1 | 1999 | 125 | 0.040 |
Why?
| | School Health Services | 1 | 2022 | 233 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2022 | 1227 | 0.040 |
Why?
| | Mental Health | | | 676 | NaN |
Why?
| | Health Education | 1 | 2022 | 339 | 0.040 |
Why?
| | Body Mass Index | 3 | 2013 | 2246 | 0.040 |
Why?
| | Minority Groups | 1 | 2000 | 246 | 0.040 |
Why?
| | Child | 3 | 2022 | 20963 | 0.040 |
Why?
| | Schools | 1 | 2022 | 446 | 0.040 |
Why?
| | Risk | 2 | 2012 | 871 | 0.040 |
Why?
| | Menopause | 2 | 2011 | 301 | 0.040 |
Why?
| | Pregnancy | 3 | 2022 | 6274 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 288 | 0.030 |
Why?
| | Postmenopause | 2 | 2009 | 366 | 0.030 |
Why?
| | Patient Selection | 1 | 2000 | 685 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 61 | 0.030 |
Why?
| | Medicaid | 1 | 2021 | 447 | 0.030 |
Why?
| | Cost of Illness | 1 | 2019 | 296 | 0.030 |
Why?
| | Urban Population | 1 | 1999 | 442 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2019 | 246 | 0.030 |
Why?
| | Child, Preschool | 1 | 2015 | 10565 | 0.030 |
Why?
| | Risk-Taking | 1 | 1999 | 361 | 0.030 |
Why?
| | Data Collection | 2 | 2014 | 660 | 0.030 |
Why?
| | Health Care Costs | 1 | 1999 | 405 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2017 | 294 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 393 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 734 | 0.030 |
Why?
| | Prejudice | 1 | 2015 | 70 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 359 | 0.030 |
Why?
| | Cancer Care Facilities | 1 | 2015 | 31 | 0.030 |
Why?
| | Poverty | 1 | 2018 | 493 | 0.030 |
Why?
| | Poverty Areas | 1 | 2014 | 37 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2015 | 139 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 189 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 221 | 0.030 |
Why?
| | Insurance, Health | 1 | 2015 | 270 | 0.030 |
Why?
| | Program Development | 1 | 2015 | 368 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2557 | 0.020 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2011 | 43 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 7074 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 54 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 476 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 20355 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 434 | 0.020 |
Why?
| | Premenopause | 1 | 2009 | 126 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2011 | 342 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1286 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 333 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 657 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 842 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 102 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 75 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 516 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 517 | 0.020 |
Why?
| | Societies, Medical | 1 | 2011 | 763 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 670 | 0.020 |
Why?
| | Women's Health | 1 | 2009 | 364 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3297 | 0.020 |
Why?
| | Attitude to Health | 1 | 2009 | 430 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 14669 | 0.010 |
Why?
| | Diabetes, Gestational | 1 | 2007 | 306 | 0.010 |
Why?
| | Cultural Characteristics | 1 | 2000 | 64 | 0.010 |
Why?
| | Language | 1 | 2000 | 288 | 0.010 |
Why?
|
|
Risendal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|